IRVINE, Calif., May 12 /PRNewswire-FirstCall/ -- Masimo Corporation
(Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through
Motion and Low-Perfusion pulse oximetry, today announced that its management
is scheduled to present at the Deutsche Bank 34th Annual Health Care
Conference in Boston, Massachusetts, on Tuesday, May 19, 2009, at 2:35 p.m.
EDT. A live audiocast of the presentation will be available on the Masimo
website at www.masimo.com. A replay of the audiocast will be available
following the live presentation.
About Masimo
Masimo (NASDAQ: MASI) develops innovative monitoring technologies that
significantly improve patient care-helping solve "unsolvable" problems. In
1995, the company debuted Measure-Through Motion and Low-Perfusion pulse
oximetry, known as Masimo SET, which virtually eliminated false alarms and
increased pulse oximetry's ability to detect life-threatening events. More
than 100 independent and objective studies demonstrate Masimo SET provides the
most reliable SpO2 and pulse rate measurements even under the most challenging
clinical conditions, including patient motion and low peripheral perfusion. In
2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry, a breakthrough
noninvasive blood constituent monitoring platform that can measure many blood
constituents that previously required invasive procedures. Rainbow SET
continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen
content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and
PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion
index (PI), allowing early detection and treatment of potentially
life-threatening conditions. Founded in 1989, Masimo has the mission of
"Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive
Monitoring to New Sites and Applications." Additional information about Masimo
and its products may be found at http://www.masimo.com.
Masimo Corporation
Investor Contact: Media Contact:
Mark P. de RaadDana Banks
Executive Vice President Manager, Public Relations
and Chief Financial Officer Masimo CorporationMasimo Corporation (949) 297-7348
(949) 297-7080 dbanks@masimo.com
mderaad@masimo.com
Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing
Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications,
Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Radical-7, Rad-87, Rad-57, Rad-9,
Rad-8, Rad-5, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or
registered trademarks of Masimo Corporation.
SOURCE Masimo Corporation
-0- 05/12/2009
/CONTACT: investors, Mark P. de Raad, Executive Vice President and Chief
Financial Officer, +1-949-297-7080, mderaad@masimo.com, or media, Dana Banks,
Manager, Public Relations, +1-949-297-7348, dbanks@masimo.com, both of Masimo
Corporation/
/Web Site: http://www.masimo.com /
(MASI)
CO: Masimo Corporation; Deutsche Bank
ST: California, Massachusetts
IN: HEA MTC BIO FIN
SU: TDS
PR
-- LA15246 --
8396 05/12/200912:00 EDThttp://www.prnewswire.com